Prostaglandin F2α inhibits SERCA2 gene transcription through an induction of Egr-1 in cultured neonatal rat cardiac myocytes

International Heart Journal

Volumn 49, Issue 3, 2008, Pages 329-342

  Hara, Shiro ^a   Arai, Masashi ^a   Tomaru, Koichi ^a   Doi, Hiroshi ^a   Koitabashi, Norimichi ^a   Iso, Tatsuya ^a   Watanabe, Atai ^a   Tanaka, Toru ^a   Maeno, Toshitaka ^a   Suga, Tatsuo ^a   Yokoyama, Tomoyuki ^a   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ca2+ ATPase; Cardiac hypertrophy; Egr 1; MAP kinase; Prostaglandin F2

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; EARLY GROWTH RESPONSE FACTOR 1; GENISTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN F2 ALPHA; PROTEIN TYROSINE KINASE; RAC PROTEIN; RAS PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1; ATP2A2 PROTEIN, RAT; EGR1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; GC RICH SEQUENCE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEART CELL CULTURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION TERMINATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; METABOLISM; WISTAR RAT;

ANIMALS; CELLS, CULTURED; DINOPROST; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANSCRIPTION, GENETIC;

EID: 49449118648     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.329     Document Type: Article

References (44)

1. Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Eng J Med 1992; 327: 998-1008. (Review)
2. Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med 1980; 69: 576-84.
3. Zarain-Herzberg A, MacLennan DH, Periasamy M. Characterization of rabbit cardiac sarco(endo)plasmic reticulum Ca2(+)-ATPase gene. J Biol Chem 1990; 265: 4670-7.
4. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 1993; 72: 463-9.
5. Takizawa T, Arai M, Yoguchi A, Tomaru K, Kurabayashi M, Nagai R. Transcription of the SERCA2 gene is-decreased in pressure-overloaded hearts: A study using in vivo direct gene transfer into living myocardium. J Mol Cell Cardiol 1999; 31: 2167-74.
6. Fuchs AR. Prostaglandin F2 alpha and oxytocin interactions in ovarian and uterine function. J Steroid Biochem 1987; 27: 1073-80. (Review)
7. Penston JG, Wormsley KG. The effects of prostaglandins on gastric emptying. Scand J Gastroenterol Suppl 1989; 164: 127-32.
8. Báker ME. Evolution of enzymatic regulation of prostaglandin action: novel connections to regulation of human sex and adrenal function, antibiotic synthesis and nitrogen fixation. Prostaglandins 1991; 42: 391-410. (Review)
9. Berger HJ, Zaret BL, Speroff L, Cohen LS, Wolfson S. Regional cardiac prostaglandin release during myocardial ischemia in anesthetized dogs. Circ Res 1976; 38: 566-71.
10. Lai J, Jin H, Yang R, et al. Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am J Physiol 1996; 271: H2197-208.
11. Chazov EI, Pomoinetsky VD, Geling NG, Orlova TR, Nekrasova AA, Smimov VN. Heart adaptation to acute pressure overload: an involvement of endogenous prostaglandins. Circ Res 1979; 45: 205-11.
12. Oudot F, Grynberg A, Sergiel JP. Eicosanoid synthesis in cardiomyocytes: influence of hypoxia, reoxygenation, and polyunsaturated fatty acids. Am J Physiol 1995; 268: H308-15.
13. Adams JW, Migita DS, Yu MK, et al. Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem 1996; 271: 1179-86.
14. Kunapuli P, Lawson JA, Rokach JA, Meinkoth JL, FitzGerald GA. Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways. J Biol Chem 1998; 273: 22442-52.
15. Yokoyama T, Arai M, Sekiguchi K, et al. Tumor necrosis factor-alpha decreases the phosphorylation levels of phospholamban and troponin I in spontaneously beating rat neonatal cardiac myocytes. J Mol Cell Cardiol 1999; 31: 261-73.
16. Watanabe N, Kurabayashi M, Shimomura Y, et al. BTEB2, a Kruppel-like transcription factor, regulates expression of the SMemb/ Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ Res 1999; 85: 182-91.
17. Fisher SA, Buttrick PM, Sukovich D, Periasamy M. Characterization of promoter elements of the rabbit cardiac sarcoplasmic reticulum Ca(2+)-ATPase gene required for expression in cardiac muscle cells. Circ Res 1993; 73: 622-8.
18. Sanchez I, Hughes RT, Mayer BJ, et al. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 1994; 372: 794-8.
19. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cell. Science 1994; 265: 808-11.
20. Minden A, Lin A, Claret FX, Abo A, Karin M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995; 81: 1147-57.
21. Thiel G, Cibelli G. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 2002; 193: 287-92. (Review)
22. Liu C, Calogero A, Ragona G, Adamson E, Mercola D. EGR-1, the reluctant suppression factor. EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity. Crit Rev Oncog 1996; 7: 101-25. (Review)
23. Sukhatme VP, Cao XM, Chang LC, et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 1988; 53: 37-43.
24. Milbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 1987; 238: 797-9.
25. Lemaire P, Revelant O, Bravo R, Chamay P. Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 1988; 85: 4691-5.
26. Bruneau BG, Piazza LA, de Bold AJ. Alpha 1-adrenergic stimulation of isolated rat atria results in discoordinate increases in natriuretic peptide secretion and gene expression and enhances Egr-1 and c-Myc expression. Endocrinology 1996; 137: 137-43.
27. Saadane N, Alpert L, Chalifour LE. Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br J Pharmacol 1999; 127: 1165-76.
28. Bahouth SW, Beauchamp MJ, Vu KN. Reciprocal regulation of beta(1)-adrenergic receptor gene transcription by Sp1 and early growth response gene 1. induction of EGR-1 inhibits the expression of the beta(1)-adrenergic receptor gene. Mol Pharmacol 2002; 61: 379-90.
29. Wang C, Dostanic S, Servant N, Chalifour LE. Egr-1 negatively regulates expression of the sodium-calcium exchanger-1 in cardiomyocytes in vitro and in vivo. Cardiovasc Res 2005; 65: 187-94.
30. Khachigian LM. Early growth response-1 in cardiovascular pathobiology. Circ Res 2006; 98: 186-91. (Review)
31. Christy B, Nathans D, DNA binding site of the growth factor-inducible protein Zif268. Proc Natl Acad Sci USA 1989; 86: 8737-41.
32. Huang RP, Fan Y, Ni Z, Mercola D, Adamson ED. Reciprocal modulation between Sp1 and Egr-1. J Cell Biochem 1997; 66: 489-99.
33. Huang RP, Liu C, Fan Y, Mercola D, Adamson ED. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res 1995; 55: 5054-62.
34. Davis W Jr, Chen ZJ, Ile KE, Tew KD. Reciprocal regulation of expression of the human adenosine 5′-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR1) and Sp-family transcription factors. Nucleic Acids Res 2003; 31: 1097-107.
35. Arai M, Yoguchi A, Takizawa T, et al. Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription. Circ Res 2000; 86: 8-14.
36. Abramovitz M, Boie Y, Nguyen T, et al. Cloning and expression of a cDNA For tho human prostanoid FP receptor. J Biol Chem 1994; 269: 2632-6.
37. Ito S, Sakamoto K, Mochizuki-Oda N, et al. Prostaglandin F2 alpha receptor is coupled to Gq in cDNA-transfected Chinese hamster ovary cells. Biochem Biophys Res Commun 1994; 200: 756-62.
38. Sugimoto Y, Hasumoto K, Namba T, et al. Cloning and expression of a cDNA for mouse prostaglandin F receptor. J Biol Chem 1994; 269: 1356-60.
39. Graves PE, Pierce KL, Bailey TJ, et al. Cloning of a receptor for prostaglandin F2 alpha from the ovine corpus luteum. Endocrinology 1995; 136: 3430-6.
40. Pierce KL, Bailey TJ, Hoyer PB, Gil DW, Woodward DF, Regan JW. Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor. J Biol Chem 1997; 272: 883-7.
41. Sugden PH, Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 1998; 83: 345-52. (Review)
42. Sugden PH. Signaling in myocardial hypertrophy: life after calcineurin? Circ Res 1999; 84: 633-46. (Review)
43. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267: 1782-8. (Review)
44. Adams JW, Sah VP, Henderson SA, Brown JH. Tyrosine kinase and c-Jun NH2-terminal kinase mediate hypertrophic responses to prostaglandin F2alpha in cultured neonatal rat ventricular myocytes. Circ Res 1998; 83: 167-78.